NX-1 (Naproxen)

(0 reviews)
Price:
Ask Suppliers /pieces
Size:
Min.Order Quantity:
500 /pieces
Supply Ability:
100000 Per month
Port:
Chittagong
Lead Time:
60
Small Order:
Ask Supplier
Payment Terms:
L/C,Western Union,T/T
Share:
iconBuyer Protection:
  • iconProduct Quality Protection
  • iconOn-time Shipment Protection
  • iconPayment Protection

Overview

Quick Details

Place of Origin:

Bangladesh

Model Number:

NX-1 (Naproxen)

Available Quantity:

100000 / Per Month

Payment Methods:

L/C,Western Union,T/T

Processing Time:

60

Est Shipping Days:

N/A

Discount:

0.00

Brand Name:

One Pharma Ltd

Currency Name:

U.S. Dollar

Length:

0

Height:

0

Width

0

Product MOQ:

500

Product FOB:

-

Product Unit:

pieces

Packaging & Delivery
Packaging: 30 Tablets contains each box Delivery: Depends

Product Description

Product Name: NX-1 (Naproxen)
Details:

NX-1 (Naproxen)

Description

Naproxen is a nonsteroidal anti-inflammatory drug with analgesic and antipyretic properties. Naproxen works by reducing the levels of prostaglandins, chemicals that are responsible for pain, fever and inflammation. Naproxen blocks the enzyme that makes prostaglandins (cyclooxygenase), resulting in lower concentrations of prostaglandins. As a consequence, inflammation, pain and fever are reduced.

 Indications and Uses

Naproxen is indicated for its anti-inflammatory and analgesic action in the treatment of rheumatoid arthritis, osteoarthritis (degenerative arthritis), ankylosing spondylitis, juvenile rheumatoid arthritis, acute gout, acute musculoskeletal disorders, post-operative pain and dysmenorrhoea. It is also indicated in the relief of mild to moderate pain, and for the treatment of tendonitis and bursitis.

Dosage and administration

Adults

For rheumatoid arthritis, osteoarthritis and ankylosing spondylitis

The usual dose is 500-1000 mg per day taken in 2 doses at 12 hours intervals after meals.

For acute gout

750 mg should be given initially, followed in 8 hours with 500 mg, and thereafter 250 mg at 12 hours intervals until the attack has passed.

For dysmennorhoea

500 mg should be given initially, followed by 250 mg at 6-8 hour intervals for up to 5 days.

For analgesia and acute muscular skeletal disorders

500 mg should be given initially, followed by 250 mg at 6-8 hour intervals.

Children over 5 years

For juvenile rheumatoid arthritis

10mg/kg/day given as 2 divided doses at 12 hour intervals.

 Contraindications

The drug is contraindicated in patients who have had allergic reactions to Naproxen. It is also contraindicated in patients in whom aspirin or other nonsteroidal anti-inflammatory/analgesic drugs induce the syndrome of asthma, rhinitis, and nasal polyps. Both types of reactions have the potential of being fatal.

 Precautions

Serious GI toxicity such as bleeding, ulceration, and perforation, can occur at any time, with or without warning symptoms, in patients treated chronically with NSAID therapy. Although minor upper GI problems, such as dyspepsia, are common, usually developing early in therapy, physicians should remain alert for ulcerations and bleeding in patients treated chronically with NSAIDs even in the absence of previous GI tract symptoms.

 Side-effects

The most common side effects from Naproxen are rash, ringing in the ears, headaches, dizziness, drowsiness, abdominal pain, nausea, diarrhea, constipation, heartburn, fluid retention and shortness of breath. Naproxen also may cause stomach and intestinal bleeding and ulcers.

 Use in pregnancy and lactation

Pregnancy: Pregnancy Category C.

Naproxen should be used during pregnancy only if the potential benefits justify the potential risks to the fetus.

Nursing mother: The Naproxen has been found in the milk of lactating women. Because of the possible adverse effects of prostaglandin-inhibiting drugs on neonates, use in nursing mothers should be avoided.

 Drug interactions

Naproxen may increase the blood levels of lithium by reducing the excretion of lithium by the kidneys. Increased levels of lithium may lead to lithium toxicity.

Naproxen may reduce the blood pressure lowering effects of blood pressure medications.

When naproxen is used in combination with aminoglycosides (e.g., gentamicin) the blood levels of the aminoglycoside may increase. This may lead to more aminoglycoside-related side effects.

Individuals taking anticoagulants (e.g. Warfarin) should avoid naproxen because naproxen also thins the blood, and excessive blood thinning may lead to bleeding.

 

Products Video link:
Supply Type:
Size Details: your own size chart are available

If you want to custom your product, please CONTACT US.

MOQ: 500 / pieces
Sample Time: 60 / Day's
Packaging: Packaging: 30 Tablets contains each box Delivery: Depends
Average Lead Time:

Size Details

NX-1 (Naproxen)
Sizes Your own size chart are available

Factory Picture

Certificate

Contact Supplier

Send your message to this supplier

KSM.Mostafizur

Verified Information

This information was Verified by BuyerSeller and is valid from the following period: 2022-04-14

The information below covers both the Gold Supplier and its related companies, which are defined according to laws and regulations, and which will also be clearly displayed in the full report >>

The competitive advantage of product line:

They Have Rich Experience In The Production Of Strictly Guard The Quality Level Give Them An Advantage In The Competition.

Export Market Distribution:
Market Total Revenue (%)
Short Lead Time:
Products Name MOQ(in the last 12month) Shortest Lead Time
T-shirt 10 Pieces 10 Days
Hoodies 10 Pieces 10 Days
Certification:
Certified Picture Certification Name Certified By Certificate No. Product Name & Model No. Available Date - Expired Date
certified picture N/A N/A N/A N/A -

Company Overview

Trade Information:
Business Type: Country / Region: Bangladesh
Main Products: Ownership: Private Owner
Total Trade Employees: Data Not updated Total Annual Revenue: Data Not updated
Year Established: 2002 Total Employees: 6
Compnay Advantage: null Total Annual Sales Volume Data Not updated
Export Percentage: Data Not updated Main Markets (%):

Product Capacity

Factory Information:
Factory Size:
Factory Country/Region:
No. of Production Lines:
No. of R & D Staff :
No. of Q & C Staff :
Annual Output Value:
Production Line:
Production Line Line NO.of In-line QC/QA Verified
Production Process yes

Trade Capabilities

Main Markets & Product(s):
Main Markets Total Revenue(%) Main Product(s)
Trade Ability:
Language Spoken: English
No. of Employees in Trade Department:
Average Lead Time: N/A
Export/Trade License Registration NO: N/A
Total Annual Revenue:
Total Export Percentage: